TY - JOUR
T1 - Ambulatory parathyroidectomy for primary hyperparathyroidism
AU - Irvin, George L.
AU - Sfakianakis, George
AU - Yeung, Luke
AU - Deriso, George T.
AU - Fishman, Lawrence M.
AU - Molinari, Alberto S.
AU - Foss, Joseph N.
PY - 1996/10
Y1 - 1996/10
N2 - Objectives: To evaluate whether the combined application of preoperative localization and intraoperative monitoring of intact parathyroid hormone (iPTH) levels could facilitate sate outpatient parathyroidectomy. Design: Consecutive patients, who had no antecedent social or medical conditions mandating hospitalization, were prospectively offered ambulatory parathyroidectomy with a mean follow-up of 7 months (range, 1-25 months). Setting: Tertiary care referral center. Patients: From 85 patients who had primary hyperparathyroidism with hypercalcemia and elevated iPTH levels, 57 were offered outpatient parathyroidectomy. Nineteen patients were asymptomatic, 3 had hypercalcemic crisis, and the others gave a history of renal stones or had complaints consistent with bone disease. Interventions: Technetium Tc 99m sestamibi scintiscans were used for preoperative localization. Monitoring iPTH levels during parathyroidectomy quantitatively assured the surgeon (G.L.I. only) when all hyperfunctioning glands were excised. Main Outcome Measure: The number of patients with out complications and with short operative times who were discharged without hospital admission or over night stay. Results: The combination of preoperative localization of abnormal parathyroid glands and a decline in circulating iPTH levels predicting postoperative normocalcemia after excision of all hyperfunctioning glands resulted in successful parathyroidectomy in 84 of 85 patients. A decreased operative time (average, 52 minutes) with minimal neck dissection permitted outpatient parathyroidectomy in 42 of 57 eligible patients. Conclusions: The combination of preoperative parathyroid scintiscan localization and iPTH level monitoring during surgery, permitted successful parathyroidectomy in an ambulatory setting in half of a consecutive series of patients with primary hyperparathyroidism. The safety, success, and likely cost savings of this approach suggest wider application.
AB - Objectives: To evaluate whether the combined application of preoperative localization and intraoperative monitoring of intact parathyroid hormone (iPTH) levels could facilitate sate outpatient parathyroidectomy. Design: Consecutive patients, who had no antecedent social or medical conditions mandating hospitalization, were prospectively offered ambulatory parathyroidectomy with a mean follow-up of 7 months (range, 1-25 months). Setting: Tertiary care referral center. Patients: From 85 patients who had primary hyperparathyroidism with hypercalcemia and elevated iPTH levels, 57 were offered outpatient parathyroidectomy. Nineteen patients were asymptomatic, 3 had hypercalcemic crisis, and the others gave a history of renal stones or had complaints consistent with bone disease. Interventions: Technetium Tc 99m sestamibi scintiscans were used for preoperative localization. Monitoring iPTH levels during parathyroidectomy quantitatively assured the surgeon (G.L.I. only) when all hyperfunctioning glands were excised. Main Outcome Measure: The number of patients with out complications and with short operative times who were discharged without hospital admission or over night stay. Results: The combination of preoperative localization of abnormal parathyroid glands and a decline in circulating iPTH levels predicting postoperative normocalcemia after excision of all hyperfunctioning glands resulted in successful parathyroidectomy in 84 of 85 patients. A decreased operative time (average, 52 minutes) with minimal neck dissection permitted outpatient parathyroidectomy in 42 of 57 eligible patients. Conclusions: The combination of preoperative parathyroid scintiscan localization and iPTH level monitoring during surgery, permitted successful parathyroidectomy in an ambulatory setting in half of a consecutive series of patients with primary hyperparathyroidism. The safety, success, and likely cost savings of this approach suggest wider application.
UR - http://www.scopus.com/inward/record.url?scp=0029838489&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029838489&partnerID=8YFLogxK
U2 - 10.1001/archsurg.1996.01430220068015
DO - 10.1001/archsurg.1996.01430220068015
M3 - Article
C2 - 8857905
AN - SCOPUS:0029838489
VL - 131
SP - 1074
EP - 1078
JO - JAMA Surgery
JF - JAMA Surgery
SN - 2168-6254
IS - 10
ER -